Galderma
Galderma is certainly the heavyweight for rosacea treatments and skincare. Rosacea sufferers will be familiar with Metrogel 1% and Oracea as well as their Cetaphil skincare range. More recently Galderma has gained approval for Mirvaso and also has CD5024/Ivermectin in development.
Recent Rosacea Blog Posts
Galderma has announced that Epsolay has been approved by the FDA for treating rosacea. Epsolay is a proprietary cream formulation of benzoyl peroxide, 5%, designated for the treatment of inflammatory lesions of rosacea in adults. In July 2021 Galderma announced an exclusive 5 year deal to market Epsolay in the US. The creators of Epsolay […]
The yet to be approved `encapsulated’ Benzoyl Peroxide 5% Cream known as Epsolay has received a huge promotional boost after the rosacea heavyweight Galderma announced a 5 year exclusive license for the US market. Having the backing of a significant licensing deal from Galderma behind them is good news for the owners of Epsolay. The […]
A mysterious tinted sunscreen has been evaluated as part of a rosacea regime and been shown to be of benefit to rosacea sufferers. So what exactly is this tinted daily SPF30 sunscreen that warranted Galderma to sponsor publication in the Journal of Cosmetic Dermatology? The article doesn’t say, but some important clues can be found. […]
Selling you two rosacea prescription rather than one. Sounds like the holy grail for someone with a portfolio of rosacea treatments. Of course `they’ are Galderma, and some recent publicity around a combination trial suggests that two may well be better than one. So, should you line up for two helpings of Galderma’s rosacea regime? […]
A patent application has emerged that suggests that Galderma might have their eye a future version of Mirvaso in a foam formulation. Read below for some clues as to why we shouldn’t be surprised to see Mirvaso Foam as a future product. NO-RINSE CHEMICAL FOAM CONTAINING BRIMONIDINE, AND USE THEREOF IN THE TREATMENT OF ROSACEA US […]
